Mankind Pharma 
Business

Mankind Pharma to acquire Bharat Serums and Vaccines for Rs 13,630 crore

The company has entered into a definitive agreement to acquire a 100 per cent stake in the Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement.

PTI

NEW DELHI: Mankind Pharma on Thursday said it will fully acquire Bharat Serums and Vaccines from Advent International for around Rs 13,630 crore.

The company has entered into a definitive agreement to acquire a 100 per cent stake in the Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement.

This strategic move marks a significant leap for the drug maker, positioning it as a leader in the Indian women's health and fertility drug market, alongside access to other high entry barrier products in critical care with established complex R&D tech platforms, it added. 

Also Read

DMK regime buried Parandur feasibility report, slams CPM state secretary P Shanmugam

Traders upbeat as Tiruchy starts domestic cargo from passenger terminal

Untreated sewage stagnation near Tiruvallur station sparks health concerns

Onion prices in Chennai's Koyambedu market surge by 71 per cent, may hit Rs 100 per kg, say traders

Family of three arrested in Chennai for cheating Rs 20 lakh on promise of government jobs